25 new manufacturing sites approved for Remdesivir production

Narendra Modi, Germany, Denmark, France, business, visit

New Delhi, April 24, 2021: Minister of State for Chemicals & Fertilizers Mansukh Mandaviya informed that 25 new manufacturing sites for Remdesivir production have been approved since 12th April.

Remdesivir is a drug used in Corona treatment.

He said, “Production capacity is now ramped up to ≥90 lakhs vials per month, earlier it was 40 lakhs vials/month. Very soon, 3 lakh vial/day will be produced . Monitoring is being done on daily basis. We would not leave any stone unturned to supply Remdesivir.”

Armed Forces Medical Services (AFMS) meanwhile has decided to import oxygen generation plants and containers from Germany, amid shortage of oxygen in the hospitals during the second wave of Covid-19 across the country. Twenty-three mobile oxygen generation plants are being airlifted from Germany that will be deployed in AFMS hospitals catering to the COVID patients.

Yoga and Naturopathy to aid the Psychosocial Rehabilitation of Covid-19 Patients

Each plant has a capacity to produce 40 litres of oxygen per minute and 2,400 litres an hour. At this rate, it can cater to 20-25 patients round the clock. The advantage of these plants is that they are easily portable.These oxygen generating plants are expected to arrive in India within a week.

In another important decision, Ministry of Defence is giving extension to Short Service Commissioned Doctors in AFMS till December 31, 2021 to tide over the current surge in medical services. This will augment the strength of AFMS by 238 more doctors.

Drone use permission to ICMR for conducting feasibility study of Covid-19 vaccine delivery